Jeannette Potts

Companies

• uniQure N.V.General counsel Mar 5, 2024 to now¹
• uniQure N.V.Officer Jun 15, 2023 to Jun 15, 2023²
• Forma Therapeutics Holdings, Inc.Officer Jun 18, 2020 to Oct 14, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• UNuniQure N.V. QURE133,246 shares⁴$3.0M at $22.37Jun 15, 2026
• FTForma Therapeutics Holdings, Inc.0 shares⁵Oct 14, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 15, 2026Sold 5,237 shares at $27.67 of uniQure N.V.⁴
• Mar 4, 2026Sold 3,412 shares at $9.06 of uniQure N.V.⁶
• Mar 4, 2026Granted 35,400 shares of uniQure N.V.⁶
• Mar 2, 2026Sold 8,578 shares at $9.95 of uniQure N.V.⁷
• Jun 16, 2025Sold 4,670 shares at $15.14 of uniQure N.V.⁸
• Mar 4, 2025Sold 7,076 shares at $10.29 of uniQure N.V.⁹
• Mar 3, 2025Granted 35,000 shares of uniQure N.V.⁹
• Jun 13, 2024Sold 4,781 shares at $4.98 of uniQure N.V.¹⁰
• Mar 1, 2024Granted 49,500 shares of uniQure N.V.¹¹
• Jun 13, 2023Granted 47,100 shares of uniQure N.V.¹²
• Oct 14, 2022U 43,958 shares of Forma Therapeutics Holdings, Inc.⁵
• Oct 14, 2022U 3,400 shares of Forma Therapeutics Holdings, Inc.⁵
• Feb 28, 2022Granted 25,000 shares of Forma Therapeutics Holdings, Inc.¹³
• Feb 23, 2022Sold 4,672 shares at $9.78 of Forma Therapeutics Holdings, Inc.¹⁴